Mumbach Maxwell R, Satpathy Ansuman T, Boyle Evan A, Dai Chao, Gowen Benjamin G, Cho Seung Woo, Nguyen Michelle L, Rubin Adam J, Granja Jeffrey M, Kazane Katelynn R, Wei Yuning, Nguyen Trieu, Greenside Peyton G, Corces M Ryan, Tycko Josh, Simeonov Dimitre R, Suliman Nabeela, Li Rui, Xu Jin, Flynn Ryan A, Kundaje Anshul, Khavari Paul A, Marson Alexander, Corn Jacob E, Quertermous Thomas, Greenleaf William J, Chang Howard Y
Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Nat Genet. 2017 Nov;49(11):1602-1612. doi: 10.1038/ng.3963. Epub 2017 Sep 25.
The challenge of linking intergenic mutations to target genes has limited molecular understanding of human diseases. Here we show that H3K27ac HiChIP generates high-resolution contact maps of active enhancers and target genes in rare primary human T cell subtypes and coronary artery smooth muscle cells. Differentiation of naive T cells into T helper 17 cells or regulatory T cells creates subtype-specific enhancer-promoter interactions, specifically at regions of shared DNA accessibility. These data provide a principled means of assigning molecular functions to autoimmune and cardiovascular disease risk variants, linking hundreds of noncoding variants to putative gene targets. Target genes identified with HiChIP are further supported by CRISPR interference and activation at linked enhancers, by the presence of expression quantitative trait loci, and by allele-specific enhancer loops in patient-derived primary cells. The majority of disease-associated enhancers contact genes beyond the nearest gene in the linear genome, leading to a fourfold increase in the number of potential target genes for autoimmune and cardiovascular diseases.
将基因间突变与靶基因联系起来的挑战限制了对人类疾病的分子理解。在此,我们表明H3K27ac HiChIP可生成罕见的原代人类T细胞亚型和冠状动脉平滑肌细胞中活性增强子和靶基因的高分辨率接触图谱。幼稚T细胞分化为辅助性T细胞17或调节性T细胞会产生亚型特异性增强子-启动子相互作用,特别是在共享DNA可及性的区域。这些数据为将分子功能赋予自身免疫和心血管疾病风险变异提供了一种有原则的方法,将数百个非编码变异与推定的基因靶标联系起来。通过CRISPR干扰和在相关增强子处的激活、表达数量性状位点的存在以及患者来源的原代细胞中的等位基因特异性增强子环,进一步支持了用HiChIP鉴定的靶基因。大多数与疾病相关的增强子与线性基因组中最近基因之外的基因接触,导致自身免疫和心血管疾病潜在靶基因数量增加了四倍。